Successfully modulated vaccine against dysentery

University of Calgary Canadian researchers have successfully developed a vaccine to prevent dysentery amib, which has claimed every year of life of 100,000 people worldwide, mainly in developing countries.

Parasite Entamobea histolyitca
(Photo: sfda.gov.sa)

Vaccine discovered by bacteriologist Kris Chadee proved 100% effective in mice exposed to the Entamoeba histolytica, the parasite causing disease.

Vaccine is given through the nose. Researchers are currently testing this vaccine in primates and humans.

Amib Entamoeba histolytica causes dysentery when entering the patient's intestinal tract. If not treated, the patient will have bloody diarrhea, dehydration and liver damage. The cause is often due to consumption or use of contaminated water. The disease can be cured but very expensive in risk countries.

Amebiasis is particularly common in Mexico, Bangladesh, India and African countries selling the desert. Children and adults with weakened immune systems, especially HIV / AIDS patients are very susceptible to this disease.

VN